#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4136	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2575	475.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1892	1892	T	597	T	537	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4136	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2575	475.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1626	1626	C	565	C,A	483,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	0	.	n	.	0	T695C	SNP	695	695	T	1313	1313	C	425	C,A	362,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1955	1955	A	500	A,G	436,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2256	2256	G	481	G	418	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2589	2589	C	536	C,A,T	462,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2663	2663	A	543	A,C	462,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3215	3215	C	527	C,T,A	432,6,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6156	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	450.2	0	HET	.	.	.	C2525T,A,G	.	2525	2525	C	3143	3143	C	544	C,T,A,G	327,124,2,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	614	folP	855	855	100.0	folP.l15.c4.ctg.1	1909	95.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1190	1192	AGC	117;117;116	A;G;C	102;103;102	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1364	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3908	104.6	1	SNP	p	S91F	1	.	.	271	273	TTC	812	814	TTC	133;133;132	T;T;C	104;109;109	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1364	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3908	104.6	1	SNP	p	G95N	0	.	.	283	285	GGC	824	826	GGC	126;126;125	G;G;C	107;106;105	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1364	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3908	104.6	1	SNP	p	D95G	1	.	.	283	285	GGC	824	826	GGC	126;126;125	G;G;C	107;106;105	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	678	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1836	110.3	1	SNP	p	G45D	0	.	.	133	135	GGC	644	646	GGC	170;168;170	G,T;G;C	142,1;140;145	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	408	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1437	85.0	0	.	n	.	0	A197.	DEL	197	197	A	861	861	A	162	A	141	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3321	125.7	1	SNP	p	D86N	0	.	.	256	258	GAC	766	768	GAC	137;137;137	G,C;A;C	115,1;109;118	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3321	125.7	1	SNP	p	R87I	0	.	.	259	261	CGT	769	771	CGT	137;138;137	C;G;T	118;118;111	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3321	125.7	1	SNP	p	S87R	1	.	.	259	261	CGT	769	771	CGT	137;138;137	C;G;T	118;118;111	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3321	125.7	1	SNP	p	R87W	0	.	.	259	261	CGT	769	771	CGT	137;138;137	C;G;T	118;118;111	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3321	125.7	1	SNP	p	S88P	0	.	.	262	264	TCC	772	774	TCC	137;137;138	T;C;C,A	112;118;113,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1236	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3151	117.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1790	1792	GGC	168;168;168	G,T;G;C	140,1;139;144	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1494	1496	GCA	165;166;166	G;C,A,G;A	142;141,1,1;140	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1497	1499	ATC	166;164;164	A;T;C,A	144;136;139,1	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1509	1511	GTG	164;164;165	G;T;G	139;137;139	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1509	1511	GTG	164;164;165	G;T;G	139;137;139	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2013	2015	ACC	128;129;130	A;C;C	114;116;115	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2067	2069	GCG	113;112;111	G;C,G;G	93;82,1;85	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2067	2069	GCG	113;112;111	G;C,G;G	93;82,1;85	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2190	2192	AGC	110;111;111	A,C;G;C	92,2;88;94	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2199	2201	GGC	112;114;115	G;G;C	95;95;97	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1094	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2933	111.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2217	2219	CCG	112;112;113	C;C;G	90;95;92	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1408	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3520	119.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1829	1831	CCG	121;121;121	C;C;G	91;96;101	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	716	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2397	89.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	845	845	C	105	C	87	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	643	645	GAA	193;193;194	G;A;A,C	156;158;163,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	892	894	AAC	166;165;167	A,C;A;C	132,1;136;144	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	931	933	GAT	160;159;158	G;A;T	135;132;133	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1054	1056	TCA	146;145;145	T,C;C;A	127,1;128;127	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1183	1185	ATC	162;161;162	A;T,C;C	145;139,1;140	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1303	1305	CAT	169;171;171	C;A;T	142;146;144	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1414	1416	GGT	184;185;186	G,T,A;G;T	146,4,1;154;152	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1513	1515	GCA	179;179;179	G,T;C;A	149,1;151;147	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	862	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2006	128.4	1	SNP	p	G120K	1	.	.	358	360	AAG	889	891	AAG	163;163;164	A,G;A;G	139,1;141;138	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2852	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5500	155.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	438	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1480	88.4	1	SNP	p	V57M	1	.	.	169	171	ATG	713	715	ATG	156;156;156	A;T;G,T	135;134;131,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
